Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 11 years
- Director since
- 2023
11 years of board service in total across 4 boards, counting each seat separately. Longest: Fate Therapeutics Inc., 3 years.
Fate Therapeutics Inc.
Director
Shattuck Labs Inc.
Director
Absci Corporation
Director
Atara Biotherapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Apr 20, 2026 | Fate Therapeutics Inc. | Other | −8,977,624 | — | — |
| Apr 20, 2026 | Fate Therapeutics Inc. | Other | +8,977,624 | — | — |
| Dec 20, 2024 | Fate Therapeutics Inc. | Other | −1,084,936 | $1.68 | $1,822,692 |
| Dec 20, 2024 | Fate Therapeutics Inc. | Other | +1,084,936 | $1.68 | $1,822,692 |
| Dec 20, 2024 | Fate Therapeutics Inc. | Open-market sale | −341,633 | $1.68 | $573,943 |
| Dec 20, 2024 | Fate Therapeutics Inc. | Open-market purchase | +397,964 | $1.68 | $668,580 |
| Dec 12, 2024 | Fate Therapeutics Inc. | Derivative conversion | +30,110 | — | — |
| Dec 11, 2024 | ADC Therapeutics SA | Open-market purchase | +50,000 | $2.28 | $114,000 |
| Dec 11, 2024 | ADC Therapeutics SA | Open-market purchase | +50,000 | $3.81 | $190,500 |
| Dec 11, 2024 | ADC Therapeutics SA | Open-market purchase | +50,000 | $2.28 | $114,000 |
| Dec 11, 2024 | ADC Therapeutics SA | Open-market purchase | +50,000 | $3.81 | $190,500 |
| Dec 4, 2024 | Shattuck Labs Inc. | Open-market sale | −133,371 | $1.25 | $166,714 |
| Dec 4, 2024 | Shattuck Labs Inc. | Open-market purchase | +133,371 | $1.25 | $166,714 |
| Dec 4, 2024 | Shattuck Labs Inc. | Other | −1,026,888 | $1.25 | $1,283,610 |
| Dec 4, 2024 | Shattuck Labs Inc. | Other | +1,026,888 | $1.25 | $1,283,610 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.